Issues
-
Cover Image
Cover Image
Aldehyde dehydrogenase (ALDH) is an enzyme widely known for its detoxifying role in metabolic processes and has been shown to be involved in the genesis of various cancers. In this issue, Carpentino and colleagues demonstrate that ALDH+ colitis cells can be grown as spheroid stem cell-like colonies and, over serialin vivo passage generate adenocarcinomas in mice, demonstrating a novel method to study the transition from colitis to cancer. Since this process is currently poorly understood, the authors approach may facilitate further studies into the mechanisms involved in this phenomenon. The cover image depicts an immunocytochemical stain of a colon cancer-derived sphere demonstrating varying levels of ALDH labeling. For details, see the article by Carpentino and colleagues on page 8208 of this issue. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Reviews
Meeting Report
Priority Reports
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
Cell, Tumor, and Stem Cell Biology
Senescence-Associated Oxidative DNA Damage Promotes the Generation of Neoplastic Cells
Epidemiology
Candidate Gene Association Study of Esophageal Squamous Cell Carcinoma in a High-Risk Region in Iran
Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Immunology
Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Molecular Biology, Pathobiology, and Genetics
Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism
Prevention
Systems Biology and Emerging Technologies
Tumor Microenvironment
Corrections
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.